Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2020 / Cilt: 30 - Sayı: 0

COVID-19 Infection and Cardiovascular Diseases

COVID-19 Enfeksiyonu ve Kardiyovasküler Hastalıklar

Pages
94–100
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this review is to provide practical advice on the issues and questions that all physicians working in the field can encounter, along with the management and diagnosis of heart failure, acute coronary syndrome, coagulopathy, and hypertension in patients with COVID-19.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although the findings of COVID-19 infection are generally related with the respiratory system, symptoms of cardiovascular disease are observed in some patients at admission.
📊
Key Findings & Data:As the highest mortality rate is seen in the elderly with known cardiovascular diseases, cardiologists have to take active parts in dealing with the disease during the COVID-19 pandemic.
💡
Conclusion & Impact:The purpose of this review is to provide practical advice on the issues and questions that all physicians working in the field can encounter, along with the management and diagnosis of heart failure, acute coronary syndrome, coagulopathy, and hypertension in patients with COVID-19.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Although the findings of COVID-19 infection are generally related with the respiratory system, symptoms of cardiovascular disease are observed in some patients at admission. As the highest mortality rate is seen in the elderly with known cardiovascular diseases, cardiologists have to take active parts in dealing with the disease during the COVID-19 pandemic. The purpose of this review is to provide practical advice on the issues and questions that all physicians working in the field can encounter, along with the management and diagnosis of heart failure, acute coronary syndrome, coagulopathy, and hypertension in patients with COVID-19.

Özet

COVID-19 enfeksiyona ait bulgular genelde solunum sistemi ile ilişkili olmakla birlikte, hastaların bir kısmında başvuru anında kalp ve damar hastalık bulguları görülmektedir. Ölüm oranının bilinen kalp ve damar hastalıkları olan yaşlılarda en yüksek düzeyde olması nedeniyle COVID-19 pandemisinde kardiyoloji uzmanlarının hastalıkla mücadelede aktif görev almaları zorunlu hâle gelmiştir. Derlememizin amacı, COVID-19’lu hastalarda kalp yetmezliği, akut koroner sendrom, koagülopati ve hipertansiyon tanı ve tedavilerinin yönetimi ile birlikte sahada çalışan tüm tıp doktorlarına karşılaştıkları sorunlar ve sorular hakkında pratik öneriler sunmaktır.

🔖

Cite This Article

EKMEKCİ, C., ÖZDOĞAN, Ö. (2020). COVID-19 Infection and Cardiovascular Diseases. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 30 - Sayı: 0, 94–100. https://ajindex.com/articles/166546

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Wang D, Hu B, Hu C, et al. Clinical Characteris- tics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. [Epub ahead of print]. [CrossRef] 2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020
  2. [CrossRef] 3. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Feb 28. [Epub ahead of print]. [CrossRef] 4. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the NewYork City Area. JAMA. 2020. [CrossRef] 5. Palmieri L, Andrianou X, Bella A, et al. Characteristics of COVID-19 patients dying in Italy Report based on available data on March 20th, 2020. COVID-19 Surveillance Group. Available at: https://www.epicentro.iss.it/coronavirus/ bollettino/Report-COVID-2019_20_marzo_eng.pdf. Accessed Mar 23, 2020. 6. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020:S0140- 6736
  3. 30566-3. 7. American College of Cardiology. Troponin and BNP Use in COVID-19. Available at: https://www.acc.org/latest-incardiology/articles/2020/03/18/15/25/troponin-and-bnp use-in covid19?utm_source=accupdate&utm_ medium=email_newsletter&utm_ content=20200320&utm_ campaign=accupdate. Accessed Mar 23, 2020. 8. Tsai SH, Lin YY, Chu SJ, Hsu CW, Cheng SM. Interpretation and use of natriuretic peptides in non-congestive heart failure settings. Yonsei Med J. 2010
  4. [CrossRef] 9. Bajwa EK, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Prognostic value of plasma N-terminal probrain natriuretic peptide levels in the acute respiratory distress syndrome. Crit Care Med. 2008
  5. [CrossRef] 10. Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diag- nosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013
  6. [CrossRef] 11. Wang D, Li S, Jiang J, et al. Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis. Sci China Life Sci.2019
  7. [CrossRef] 12. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SA